BCL11A and neoplasm: In addition, when we analyzed AC cases, we noted higher nuclear expression of BCL11A in pT3 and pT4 tumors compared to pT1 and pT2 (p = 0.0134) and in cases with tumor stage III and IV compared to I and II (p = 0.0341; Table 1).